Answers are grounded in this paper and cite their sources.
Assesses oral toxicity of Breastin in C57BL6 mice, indicating safety at lower doses.
Breastin is an aqueous extract from Nerium oleander leaves with a wide range of biological applications, including anticancer, anti-inflammatory, antiviral, neurodegenerative, and antibacterial effects. The present study was conducted to evaluate the oral acute and sub-acute toxicity of the Breastin preparation (BP) in C57BL6 mice by adopting methods explained in the guidelines of the Organisation for Economic Co-operation and Development (OECD). In the acute toxicity study (OECD 425), animals received 175, 550, and 1750mg/kg of BP orally for 14 days. The oral LD50 value was found to be 1195mg/kg body weight. In the subacute toxicity study (OECD 407), mice were fed with BP at doses of 5, 20, and 80mg/kg daily for 28 days and observed for haematological, biochemical, and histopathological conditions. Furthermore, neither any clinical symptoms nor biochemical or histological variation in mice treated with 5, 20 and 80mg/kg compared to the control group was observed. Although no significant difference was observed in differential leucocyte and reticulocyte count, haematological parameters, and serum electrolytes, an increase in cholesterol, ans triglyceride and a significant decrease in albumin, serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT) levels were observed in male mice at a dose of 80 mg/kg. Based on the present data, BP was found to be safe ≤ 5mg/kg/day. This study provides preliminary results on the toxicological profile of BP extracted from Nerium oleander leaves, opening a gateway for the future research and translation to the clinics.
No takes yet. Share an insight, caveat, or question.
Rashan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: